跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,761 条关于
“PTLD”
全部
1,761
临床试验
1,610
药物
35
机构
1
资讯
115
2年前
Atara Biotherapeutics Submits BLA for Tabelecleucel to Treat EBV+ PTLD
2年前
FDA Grants Priority Review to Tabelecleucel for EBV+ PTLD Treatment
去年
Tabelecleucel Shows Sustained Efficacy in EBV+ PTLD, FDA Decision Expected in January 2025
去年
Belatacept Use and Risk of Post-Transplant Lymphoproliferative Disorder in Kidney Transplant Recipients
去年
Atara Biotherapeutics' Ebvallo Nears EU Approval for Transplant Complication Therapy
去年
Viracta Therapeutics' Nana-Val Shows Promise in Post-Transplant Lymphoproliferative Disorder
9个月前
Pierre Fabre's Tabelecleucel Shows 47.7% Response Rate in Phase 3 Trial for Rare Post-Transplant Cancer
去年
FDA Decision on Atara Biotherapeutics' Tab-cel Expected Soon
7个月前
Fred Hutch Scientists Develop First Human Monoclonal Antibodies to Block Epstein-Barr Virus Infection
去年
Cell Therapy Shows Promise for EBV-Driven Post-Transplant Lymphoproliferative Disease
第 1 页,共 12 页
上一页
下一页